ARTICLE | Clinical News
Trumenba regulatory update
March 31, 2017 5:19 AM UTC
EMA's CHMP recommended approval of an MAA from Pfizer for Trumenba meningococcal group B vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals a...
BCIQ Company Profiles